ASRT

Assertio Holdings, Inc. · Healthcare

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$7K

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Latest filing

May 15, 2026

Stark David Matthew

Assertio Holdings, Inc. (ASRT) has 16 SEC Form 4 filings (26 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: May 15, 2026.

Inside the rolling window, 1 insider at Assertio Holdings, Inc. reported no open-market purchases and 1 open-market sale totaling $7K. The most recent open-market filing is a sale of 597 shares by Director Stark David Matthew, dated Nov 10, 2025, worth $7K.

  • Industry:Drug Manufacturers - Specialty & Generic
  • CEO:Mark L. Reisenauer
  • Employees:58
  • HQ:Lake Forest, IL, US
  • IPO:1997-12-03
Source
Sale$7KNov 12SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 insider filings does ASRT have?

Assertio Holdings, Inc. (ASRT) has 16 SEC Form 4 filings (26 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: May 15, 2026.

When was the most recent SEC Form 4 filing for ASRT?

The most recent Form 4 filing for ASRT on Tracefour is dated May 15, 2026.

What is the total insider buy and sell value at ASRT in the current window?

Inside the rolling window, insiders at ASRT bought $0 and sold $7K based on SEC Form 4 filings.

Can I get alerts for ASRT insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Assertio Holdings, Inc. (ASRT). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

Assertio Holdings, Inc. is in the Healthcare sector.